$CTHR
CHARLES & COLVARD LTD

2021 Q2 Form 10-Q Financial Statement

#000114036121016259 Filed on May 07, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2021 Q1 2020 Q1
Revenue $9.727M $9.436M $6.491M
YoY Change 119.56% 45.37% -17.86%
Cost Of Revenue $5.330M $5.093M $9.172M
YoY Change 123.97% -44.47% 121.0%
Gross Profit $4.396M $4.343M -$2.681M
YoY Change 114.45% -261.98% -171.45%
Gross Profit Margin 45.2% 46.02% -41.3%
Selling, General & Admin $3.300M $3.304M $3.513M
YoY Change 15.79% -5.95% 18.9%
% of Gross Profit 75.07% 76.08%
Research & Development $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization $147.1K $148.5K $132.0K
YoY Change 22.6% 12.45% 4.94%
% of Gross Profit 3.35% 3.42%
Operating Expenses $3.300M $3.304M $3.513M
YoY Change 15.79% -5.95% 18.9%
Operating Profit $1.096M $1.039M -$6.194M
YoY Change -237.02% -116.77% -876.68%
Interest Expense -$1.180K $2.412K $116.00
YoY Change -111.8% 1979.31% -59.58%
% of Operating Profit -0.11% 0.23%
Other Income/Expense, Net -$1.872K $39.10K
YoY Change -104.79% -7983.67%
Pretax Income $2.047M $1.037M -$6.155M
YoY Change -298.77% -116.84% -872.26%
Income Tax -$6.334M $500.00 $493.00
% Of Pretax Income -309.37% 0.05%
Net Earnings $8.381M $1.036M -$6.155M
YoY Change -913.71% -116.83% -856.1%
Net Earnings / Revenue 86.17% 10.98% -94.83%
Basic Earnings Per Share $0.04 -$0.21
Diluted Earnings Per Share $262.5K $0.03 -$0.21
COMMON SHARES
Basic Shares Outstanding 29.85M 29.32M 28.66M
Diluted Shares Outstanding 30.53M 28.66M

Balance Sheet

Concept 2021 Q2 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $21.30M $19.61M $11.87M
YoY Change 52.27% 65.21% 195.27%
Cash & Equivalents $21.30M $19.61M $11.87M
Short-Term Investments
Other Short-Term Assets $1.097M $1.160M $1.270M
YoY Change -39.07% -8.66% -16.45%
Inventory $11.45M $12.64M $5.315M
Prepaid Expenses
Receivables $1.662M $2.138M $1.646M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $35.76M $35.79M $20.10M
YoY Change 49.57% 78.05% 9.62%
LONG-TERM ASSETS
Property, Plant & Equipment $875.9K $930.7K $1.057M
YoY Change -12.33% -11.98% -6.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $49.66K $49.66K $52.81K
YoY Change -3.5% -5.97% -99.77%
Total Long-Term Assets $29.16M $21.60M $28.31M
YoY Change 16.66% -23.7% 18.22%
TOTAL ASSETS
Total Short-Term Assets $35.76M $35.79M $20.10M
Total Long-Term Assets $29.16M $21.60M $28.31M
Total Assets $64.92M $57.40M $48.42M
YoY Change 32.75% 18.54% 14.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.774M $2.921M $4.126M
YoY Change -25.98% -29.22% 6.07%
Accrued Expenses $2.282M $2.053M $1.098M
YoY Change 18.7% 86.92% -18.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $640.0K
YoY Change -100.0%
Total Short-Term Liabilities $5.622M $6.133M $5.843M
YoY Change -13.32% 4.97% 11.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $320.0K $0.00
YoY Change -100.0%
Other Long-Term Liabilities $3.611M $3.790M $360.0K
YoY Change 1619.39% 952.78% -52.63%
Total Long-Term Liabilities $3.611M $4.114M $356.9K
YoY Change 267.34% 1052.69% -53.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.622M $6.133M $5.843M
Total Long-Term Liabilities $3.611M $4.114M $356.9K
Total Liabilities $9.233M $10.25M $6.199M
YoY Change 23.62% 65.28% 3.5%
SHAREHOLDERS EQUITY
Retained Earnings -$25.98M -$34.36M -$37.76M
YoY Change -33.03% -9.01%
Common Stock $81.67M $81.51M $79.98M
YoY Change 1.8% 1.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $55.69M $47.15M $42.22M
YoY Change
Total Liabilities & Shareholders Equity $64.92M $57.40M $48.42M
YoY Change 32.75% 18.54% 14.49%

Cashflow Statement

Concept 2021 Q2 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $8.381M $1.036M -$6.155M
YoY Change -913.71% -116.83% -856.1%
Depreciation, Depletion And Amortization $147.1K $148.5K $132.0K
YoY Change 22.6% 12.45% 4.94%
Cash From Operating Activities $1.803M $2.260M -$1.330M
YoY Change -0.93% -269.92% -178.7%
INVESTING ACTIVITIES
Capital Expenditures -$113.5K $78.63K $73.60K
YoY Change 62.1% 6.84% 41.82%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$250.0K
YoY Change
Cash From Investing Activities -$113.5K -$350.0K -$110.0K
YoY Change 62.1% 218.18% 120.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 80.09K 890.0K 0.000
YoY Change -91.74%
NET CHANGE
Cash From Operating Activities 1.803M 2.260M -1.330M
Cash From Investing Activities -113.5K -350.0K -110.0K
Cash From Financing Activities 80.09K 890.0K 0.000
Net Change In Cash 1.770M 2.800M -1.440M
YoY Change -34.94% -294.44% -187.8%
FREE CASH FLOW
Cash From Operating Activities $1.803M $2.260M -$1.330M
Capital Expenditures -$113.5K $78.63K $73.60K
Free Cash Flow $1.917M $2.181M -$1.404M
YoY Change 1.41% -255.41% -185.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2920570
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3748235
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5058139
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
670718
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2052958
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1922332
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2138158
CY2021Q1 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
81644
CY2020Q2 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
89517
CY2020Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
7947
CY2021Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
9407
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
25880165
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
25575521
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
146725
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
87938
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
212380
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
107355
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
76916
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021Q1 us-gaap Assets
Assets
57397254
CY2020Q2 us-gaap Assets
Assets
48904587
CY2021Q1 us-gaap Assets Current
AssetsCurrent
35794316
CY2020Q2 us-gaap Assets Current
AssetsCurrent
23909069
CY2021Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
21602938
CY2020Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
24995518
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19608801
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13993032
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1105230
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13006545
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14617234
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19675373
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11901315
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29852950
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28949410
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29852950
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28949410
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
55932808
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
54342864
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
680389
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
794740
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9171932
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5093452
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15457215
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18579069
us-gaap Costs And Expenses
CostsAndExpenses
25075315
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
12684918
us-gaap Costs And Expenses
CostsAndExpenses
30035799
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
8397485
CY2021Q1 us-gaap Deferred Costs Leasing Net Current
DeferredCostsLeasingNetCurrent
300000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
366322
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
419511
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
148450
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
132019
us-gaap Dividends Cash
DividendsCash
0
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
395006
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
726294
CY2021Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2020Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
191508
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
170151
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-603
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-206
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1058
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
994254
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3278246
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1092683
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3547441
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6154767
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1036699
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5132651
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4431030
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1460
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1240
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
472
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
493
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9050
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2050
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3604002
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-404713
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-827665
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
678501
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1240
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1460
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1617077
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-50626
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3556653
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1559759
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3451872
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-326146
CY2020Q1 us-gaap Interest Expense
InterestExpense
116
us-gaap Interest Expense
InterestExpense
7318
CY2021Q1 us-gaap Interest Expense
InterestExpense
2412
us-gaap Interest Expense
InterestExpense
535
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Interest Paid Net
InterestPaidNet
535
us-gaap Inventory Write Down
InventoryWriteDown
128000
us-gaap Inventory Write Down
InventoryWriteDown
5620991
CY2020Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
23190702
CY2021Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
16307138
CY2021Q1 us-gaap Inventory Net
InventoryNet
12639062
CY2020Q2 us-gaap Inventory Net
InventoryNet
7443257
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
39425
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
540
us-gaap Investment Income Interest
InvestmentIncomeInterest
146182
us-gaap Investment Income Interest
InvestmentIncomeInterest
5126
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
893660
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
381023
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
317327
CY2021Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
161852
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
918236
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4679895
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
943487
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
869742
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
575591
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57397254
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48904587
CY2020Q2 us-gaap Liabilities
Liabilities
7469010
CY2021Q1 us-gaap Liabilities
Liabilities
10246807
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
982950
CY2021Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4113703
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6133104
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6486060
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">1.</td><td style="width: auto; vertical-align: top;"><div style="color: rgb(0, 0, 0); font-weight: bold;">DESCRIPTION OF BUSINESS</div></td></tr></table><div><br /></div><div>Charles &amp; Colvard, Ltd. (the &#8220;Company&#8221;), a North Carolina corporation, was founded in 1995. The Company manufactures, markets, and distributes <font style="font-style: italic;">Charles &amp; Colvard Created Moissanite</font><sup style="font-style: italic; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (hereinafter referred to as moissanite or moissanite jewels) and finished jewelry featuring moissanite, including <font style="font-style: italic;">Forever One&#8482;</font>, our premium moissanite gemstone brand, for sale in the worldwide fine jewelry market. The Company also markets and distributes <font style="font-style: italic;">Caydia</font>&#8482; lab grown diamonds and finished jewelry featuring lab grown diamonds for sale in the worldwide fine jewelry market. Moissanite, also known by its chemical name silicon carbide (&#8220;SiC&#8221;), is a rare mineral first discovered in a meteorite crater. Because naturally occurring SiC crystals are too small for commercial use, larger crystals must be grown in a laboratory. Lab grown diamonds are also grown using technology that replicates the natural diamond growing process. The only differentiation between that of a lab grown diamond and a mined diamond is its origin. The result is a man-made diamond that is chemically, physically, and optically the same as those grown beneath the earth&#8217;s surface. The Company sells loose moissanite jewels, loose lab grown diamonds, and finished jewelry featuring both moissanite and lab grown diamonds at wholesale prices to distributors, manufacturers, retailers, and designers, including some of the largest distributors and jewelry manufacturers in the world. The Company&#8217;s finished jewelry and loose moissanite jewels and lab grown diamonds that are mounted into fine jewelry by other manufacturers are sold at retail outlets and via the Internet. The Company sells at retail prices to end-consumers through its wholly owned operating subsidiary, charlesandcolvard.com, LLC, third-party online marketplaces, drop-ship, and other pure-play, exclusively e-commerce outlets. The Company also sells at discount retail prices to end-consumers on its own transactional website, moissaniteoutlet.com, through charlesandcolvard.com, LLC.</div></div>
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1571538
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4667534
us-gaap Net Income Loss
NetIncomeLoss
4429570
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1036227
us-gaap Net Income Loss
NetIncomeLoss
-5133891
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
516576
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
117000
us-gaap Operating Lease Cost
OperatingLeaseCost
352000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
192000
us-gaap Operating Lease Cost
OperatingLeaseCost
473000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
584143
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4123956
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y6M29D
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-6155260
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
207319
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
814050
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
2519077
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
874266
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-466172
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-622486
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1013091
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
932480
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1872
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
144589
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
39103
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2795
CY2020Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
0
CY2021Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
250000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
us-gaap Operating Lease Payments
OperatingLeasePayments
481000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
160000
us-gaap Operating Lease Payments
OperatingLeasePayments
500000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
172000
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0281
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
4298872
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
203003
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3782296
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
622493
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1038571
us-gaap Operating Income Loss
OperatingIncomeLoss
4433825
us-gaap Operating Income Loss
OperatingIncomeLoss
-5277240
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6193870
us-gaap Restricted Stock Expense
RestrictedStockExpense
58539
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
930679
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
999061
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
53514
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
151000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3908249
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3900000
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
49657
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
51461
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9063
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1
CY2021Q1 us-gaap Other Inventory Supplies
OtherInventorySupplies
99674
CY2020Q2 us-gaap Other Inventory Supplies
OtherInventorySupplies
88034
CY2021Q1 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
322000
CY2020Q2 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
772000
CY2021Q1 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
643000
CY2020Q2 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
193000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
71347
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
26374
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
394825
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
346112
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
73597
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
78628
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
250000
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
0
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1091723
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1177860
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="color: rgb(0, 0, 0);"><font style="font-weight: bold; font-style: italic;">Reclassifications</font> &#8211; Certain amounts in the Company&#8217;s condensed consolidated financial statements for the nine months ended March 31, 2020 have been reclassified to conform to current presentation related to certain customer credit balances that were reclassified from accounts payable to accrued expenses and other liabilities in the amount of approximately $274,000. These reclassifications had no impact on the Company&#8217;s condensed consolidated financial position or condensed consolidated results of operations as of or for the periods ended March 31, 2021 and 2020.</div></div>
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
932480
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1013091
CY2021Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
31604
us-gaap Restricted Stock Expense
RestrictedStockExpense
85681
CY2020Q2 us-gaap Restricted Cash
RestrictedCash
624202
CY2021Q1 us-gaap Restricted Cash
RestrictedCash
66572
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34357882
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38787452
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29509140
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6491048
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24758559
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9436056
CY2021Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
506746
CY2020Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
295651
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6339854
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2518732
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2211350
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7909289
us-gaap Share Based Compensation
ShareBasedCompensation
272209
us-gaap Share Based Compensation
ShareBasedCompensation
214477
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28967946
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28656910
CY2021Q1 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
57884
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
-144628
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
76916
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0
CY2020Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0
CY2020Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
114999
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
898092
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
932480
CY2020Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2020Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
43874
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
155938
CY2021Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
45312
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
186528
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
47150447
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
41435577
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
46205642
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
47557821
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
48518596
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
42417198
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
42218708
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
45139212
CY2020Q2 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
338355
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
1000
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
500
CY2020Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
500
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
1000
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div><font style="font-weight: bold; font-style: italic;">Use of Estimates </font>&#8211; The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. As future events and their effects, including the impact of the COVID-19 pandemic and the related responses, cannot be fully determined with precision, actual results of operations, cash flow, and financial position could differ significantly from estimates. The most significant estimates impacting the Company&#8217;s condensed consolidated financial statements relate to valuation and classification of inventories, accounts receivable reserves, deferred tax assets, and revenue recognition. Changes in estimates are reflected in the condensed consolidated financial statements in the period in which the change in estimate occurs.</div></div>
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
699783
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1205004
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2021Q1 cthr Shelf Registration Statement Available Amount
ShelfRegistrationStatementAvailableAmount
13990000
CY2020Q1 cthr Reversal Of Restricted Stock Or Unit Expense
ReversalOfRestrictedStockOrUnitExpense
188502
cthr Provision For Accounts Receivable Discounts
ProvisionForAccountsReceivableDiscounts
6416
cthr Provision For Accounts Receivable Discounts
ProvisionForAccountsReceivableDiscounts
29123
cthr Provision For Recovery Of Sales Returns
ProvisionForRecoveryOfSalesReturns
67000
cthr Provision For Recovery Of Sales Returns
ProvisionForRecoveryOfSalesReturns
108000
CY2020Q1 cthr Apic Share Based Payment Arrangement Decrease For Cost Recognition
ApicShareBasedPaymentArrangementDecreaseForCostRecognition
144628
CY2021Q1 cthr Lessee Operating Lease Rent Abatement
LesseeOperatingLeaseRentAbatement
214000
cthr Lessee Operating Lease Minimum Notice Period For Extension Of Lease Term
LesseeOperatingLeaseMinimumNoticePeriodForExtensionOfLeaseTerm
P270D
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28625723
CY2021Q1 cthr Lessee Operating Lease Area
LesseeOperatingLeaseArea
36350
CY2021Q1 cthr Lessee Operating Lease Allowance For Leasehold Improvements
LesseeOperatingLeaseAllowanceForLeaseholdImprovements
545000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29320434
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28656910
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29667729
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30525438
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28625723
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
CHARLES & COLVARD LTD
dei Entity Central Index Key
EntityCentralIndexKey
0001015155
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29852950
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Shell Company
EntityShellCompany
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 cthr Shelf Registration Statement
ShelfRegistrationStatement
25000000
CY2021Q1 cthr Work In Process Inventories Issued To Active Production Jobs
WorkInProcessInventoriesIssuedToActiveProductionJobs
1880000
CY2020Q2 cthr Work In Process Inventories Issued To Active Production Jobs
WorkInProcessInventoriesIssuedToActiveProductionJobs
1340000
CY2020Q2 cthr Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
30633959
CY2021Q1 cthr Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
28946200

Files In Submission

Name View Source Status
0001140361-21-016259-index-headers.html Edgar Link pending
0001140361-21-016259-index.html Edgar Link pending
0001140361-21-016259.txt Edgar Link pending
0001140361-21-016259-xbrl.zip Edgar Link pending
brhc10023906_10q.htm Edgar Link pending
brhc10023906_ex31-1.htm Edgar Link pending
brhc10023906_ex31-2.htm Edgar Link pending
brhc10023906_ex32-1.htm Edgar Link pending
brhc10023906_ex32-2.htm Edgar Link pending
cthr-20210331.xml Edgar Link completed
cthr-20210331.xsd Edgar Link pending
cthr-20210331_cal.xml Edgar Link unprocessable
cthr-20210331_def.xml Edgar Link unprocessable
cthr-20210331_lab.xml Edgar Link unprocessable
cthr-20210331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending